| Composition: | Calcium-3-methyl-2-oxo-valerate (α-ketoanalogue to isoleucine, calcium salt) 67 mg + calcium-4-methyl-2-oxo-valerate (α-ketoanalogue to leucine, calcium salt) 101 mg + calcium-2-oxo-3-phenylpropionate (α-ketoanalogue to phenylalanine, calcium salt) 68 |
| Packaging: | 10x10 |
✓ Alleviates the decrease in glomerular filtration rate and maintains body mass index.
✓ Improves and maintains protein nutrition In patients with chronic renal failure.
✓ Effective in protecting renal deterioration in patients with advanced chronic kidney disease stages without adverse effects on nutrition and cholesterol levels.
✓ Reduces the risk of initiating long-term dialysis and slows the progression of chronic kidney disease.